<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">33594539</PMID><DateCompleted><Year>2021</Year><Month>09</Month><Day>17</Day></DateCompleted><DateRevised><Year>2021</Year><Month>09</Month><Day>17</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1590-3478</ISSN><JournalIssue CitedMedium="Internet"><Volume>42</Volume><Issue>10</Issue><PubDate><Year>2021</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology</Title><ISOAbbreviation>Neurol Sci</ISOAbbreviation></Journal><ArticleTitle>MR spectroscopy and imaging-derived measurements in the supplementary motor area for biomarkers of amyotrophic lateral sclerosis.</ArticleTitle><Pagination><StartPage>4257</StartPage><EndPage>4263</EndPage><MedlinePgn>4257-4263</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10072-021-05107-3</ELocationID><Abstract><AbstractText>The diagnosis of amyotrophic lateral sclerosis (ALS) requires both upper and lower motor neuron signs. However, quite a few patients with ALS lack the upper motor neuron sign during the disease. This study sought to investigate whether metabolites, including glutamate (Glu), N-acetyl aspartate (NAA), and gamma aminobutyric acid (GABA), in the supplementary motor area (SMA) measured by magnetic resonance spectroscopy (MRS), could be a surrogate biomarker for ALS. Twenty-five patients with ALS and 12 controls underwent 3.0-T MR scanning, which measured Glu, NAA, and GABA. Finally, receiver operating characteristic (ROC) curves were created and the area under curve (AUC) was calculated to assess the diagnostic power. Logistic regression analysis revealed the usefulness of both Glu and NAA for the differentiation of ALS from controls (Glu, P = 0.009; NAA, P = 0.033). The ratio of Glu to NAA or GABA was significantly increased in patients with ALS (Glu/NAA, P = 0.027; Glu/GABA, P = 0.003). Both the AUCs were more than 0.7, with high specificity but low sensitivity. The present findings might indicate that both the Glu/NAA and the Glu/GABA ratios in the SMA could be potential biomarkers for the diagnosis of ALS.</AbstractText><CopyrightInformation>&#xa9; 2021. Fondazione Societ&#xe0; Italiana di Neurologia.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sako</LastName><ForeName>Wataru</ForeName><Initials>W</Initials><Identifier Source="ORCID">0000-0003-2009-2486</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan. dwsako@tokushima-u.ac.jp.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Izumi</LastName><ForeName>Yuishin</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Neurology, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abe</LastName><ForeName>Takashi</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Radiology, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Haji</LastName><ForeName>Shotaro</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurology, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Murakami</LastName><ForeName>Nagahisa</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Neurology, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Osaki</LastName><ForeName>Yusuke</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Neurology, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Matsumoto</LastName><ForeName>Yuki</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Radiology, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Harada</LastName><ForeName>Masafumi</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Radiology, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kaji</LastName><ForeName>Ryuji</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Neurology, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>02</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>Italy</Country><MedlineTA>Neurol Sci</MedlineTA><NlmUniqueID>100959175</NlmUniqueID><ISSNLinking>1590-1874</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>30KYC7MIAI</RegistryNumber><NameOfSubstance UI="D001224">Aspartic Acid</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001224" MajorTopicYN="N">Aspartic Acid</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008279" MajorTopicYN="N">Magnetic Resonance Imaging</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009682" MajorTopicYN="N">Magnetic Resonance Spectroscopy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009044" MajorTopicYN="Y">Motor Cortex</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">GABA</Keyword><Keyword MajorTopicYN="N">Glutamate</Keyword><Keyword MajorTopicYN="N">MRS</Keyword><Keyword MajorTopicYN="N">N-acetyl aspartate</Keyword><Keyword MajorTopicYN="N">Supplementary motor area</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>5</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>1</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>2</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>9</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>2</Month><Day>17</Day><Hour>5</Hour><Minute>58</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33594539</ArticleId><ArticleId IdType="doi">10.1007/s10072-021-05107-3</ArticleId><ArticleId IdType="pii">10.1007/s10072-021-05107-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Riku Y, Atsuta N, Yoshida M, Tatsumi S, Iwasaki Y, Mimuro M, Watanabe H, Ito M, Senda J, Nakamura R, Koike H, Sobue G (2014) Differential motor neuron involvement in progressive muscular atrophy: a comparative study with amyotrophic lateral sclerosis. BMJ Open 4(5):e005213</Citation><ArticleIdList><ArticleId IdType="pubmed">24833696</ArticleId><ArticleId IdType="pmc">4025414</ArticleId></ArticleIdList></Reference><Reference><Citation>Novotny EJ Jr, Fulbright RK, Pearl PL, Gibson KM, Rothman DL (2003) Magnetic resonance spectroscopy of neurotransmitters in human brain. Ann Neurol 54(Suppl 6):S25&#x2013;S31</Citation><ArticleIdList><ArticleId IdType="pubmed">12891651</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiernan MC, Vucic S, Cheah BC, Turner MR, Eisen A, Hardiman O, Burrell JR, Zoing MC (2011) Amyotrophic lateral sclerosis. Lancet 377(9769):942&#x2013;955</Citation><ArticleIdList><ArticleId IdType="pubmed">21296405</ArticleId></ArticleIdList></Reference><Reference><Citation>Bradley WG, Bowen BC, Pattany PM, Rotta F (1999) 1H-magnetic resonance spectroscopy in amyotrophic lateral sclerosis. J Neurol Sci 169(1-2):84&#x2013;86</Citation><ArticleIdList><ArticleId IdType="pubmed">10540013</ArticleId></ArticleIdList></Reference><Reference><Citation>Pioro EP, Majors AW, Mitsumoto H, Nelson DR, Ng TC (1999) 1H-MRS evidence of neurodegeneration and excess glutamate + glutamine in ALS medulla. Neurology 53(1):71&#x2013;79</Citation><ArticleIdList><ArticleId IdType="pubmed">10408539</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowen BC, Pattany PM, Bradley WG, Murdoch JB, Rotta F, Younis AA, Duncan RC, Quencer RM (2000) MR imaging and localized proton spectroscopy of the precentral gyrus in amyotrophic lateral sclerosis. AJNR Am J Neuroradiol 21(4):647&#x2013;658</Citation><ArticleIdList><ArticleId IdType="pubmed">10782773</ArticleId><ArticleId IdType="pmc">7976640</ArticleId></ArticleIdList></Reference><Reference><Citation>Pohl C, Block W, Karitzky J, Traber F, Schmidt S, Grothe C et al (2001) Proton magnetic resonance spectroscopy of the motor cortex in 70 patients with amyotrophic lateral sclerosis. Arch Neurol 58(5):729&#x2013;735</Citation><ArticleIdList><ArticleId IdType="pubmed">11346367</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuff N, Rooney WD, Miller R, Gelinas DF, Amend DL, Maudsley AA, Weiner MW (2001) Reanalysis of multislice (1)H MRSI in amyotrophic lateral sclerosis. Magn Reson Med 45(3):513&#x2013;516</Citation><ArticleIdList><ArticleId IdType="pubmed">11241711</ArticleId></ArticleIdList></Reference><Reference><Citation>Rule RR, Suhy J, Schuff N, Gelinas DF, Miller RG, Weiner MW (2004) Reduced NAA in motor and non-motor brain regions in amyotrophic lateral sclerosis: a cross-sectional and longitudinal study. Amyotroph Lateral Scler Other Motor Neuron Disord 5(3):141&#x2013;149</Citation><ArticleIdList><ArticleId IdType="pubmed">15512902</ArticleId><ArticleId IdType="pmc">2744639</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S, Poptani H, Woo JH, Desiderio LM, Elman LB, McCluskey LF et al (2006) Amyotrophic lateral sclerosis: diffusion-tensor and chemical shift MR imaging at 3.0 T. Radiology 239(3):831&#x2013;838</Citation><ArticleIdList><ArticleId IdType="pubmed">16641339</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitsumoto H, Ulug AM, Pullman SL, Gooch CL, Chan S, Tang MX et al (2007) Quantitative objective markers for upper and lower motor neuron dysfunction in ALS. Neurology 68(17):1402&#x2013;1410</Citation><ArticleIdList><ArticleId IdType="pubmed">17452585</ArticleId></ArticleIdList></Reference><Reference><Citation>Unrath A, Ludolph AC, Kassubek J (2007) Brain metabolites in definite amyotrophic lateral sclerosis. A longitudinal proton magnetic resonance spectroscopy study. J Neurol 254(8):1099&#x2013;1106</Citation><ArticleIdList><ArticleId IdType="pubmed">17431700</ArticleId></ArticleIdList></Reference><Reference><Citation>Sivak S, Bittsansky M, Kurca E, Turcanova-Koprusakova M, Grofik M, Nosal V et al (2010) Proton magnetic resonance spectroscopy in patients with early stages of amyotrophic lateral sclerosis. Neuroradiology 52(12):1079&#x2013;1085</Citation><ArticleIdList><ArticleId IdType="pubmed">20369234</ArticleId></ArticleIdList></Reference><Reference><Citation>Verma G, Woo JH, Chawla S, Wang S, Sheriff S, Elman LB, McCluskey LF, Grossman M, Melhem ER, Maudsley AA, Poptani H (2013) Whole-brain analysis of amyotrophic lateral sclerosis by using echo-planar spectroscopic imaging. Radiology 267(3):851&#x2013;857</Citation><ArticleIdList><ArticleId IdType="pubmed">23360740</ArticleId><ArticleId IdType="pmc">3662903</ArticleId></ArticleIdList></Reference><Reference><Citation>Han J, Ma L (2010) Study of the features of proton MR spectroscopy ((1)H-MRS) on amyotrophic lateral sclerosis. J Magn Reson Imaging 31(2):305&#x2013;308</Citation><ArticleIdList><ArticleId IdType="pubmed">20099342</ArticleId></ArticleIdList></Reference><Reference><Citation>Foerster BR, Callaghan BC, Petrou M, Edden RA, Chenevert TL, Feldman EL (2012) Decreased motor cortex gamma-aminobutyric acid in amyotrophic lateral sclerosis. Neurology 78(20):1596&#x2013;1600</Citation><ArticleIdList><ArticleId IdType="pubmed">22517106</ArticleId><ArticleId IdType="pmc">22517106</ArticleId></ArticleIdList></Reference><Reference><Citation>Foerster BR, Pomper MG, Callaghan BC, Petrou M, Edden RA, Mohamed MA et al (2013) An imbalance between excitatory and inhibitory neurotransmitters in amyotrophic lateral sclerosis revealed by use of 3-T proton magnetic resonance spectroscopy. JAMA Neurol 70(8):1009&#x2013;1016</Citation><ArticleIdList><ArticleId IdType="pubmed">23797905</ArticleId><ArticleId IdType="pmc">4382938</ArticleId></ArticleIdList></Reference><Reference><Citation>Foerster BR, Carlos RC, Dwamena BA, Callaghan BC, Petrou M, Edden RA et al (2014) Multimodal MRI as a diagnostic biomarker for amyotrophic lateral sclerosis. Ann Clin Transl Neurol 1(2):107&#x2013;114</Citation><ArticleIdList><ArticleId IdType="pubmed">25356389</ArticleId><ArticleId IdType="pmc">4212480</ArticleId></ArticleIdList></Reference><Reference><Citation>Sako W, Abe T, Izumi Y, Harada M, Kaji R (2016) The ratio of N-acetyl aspartate to glutamate correlates with disease duration of amyotrophic lateral sclerosis. J Clin Neurosci 27:110&#x2013;113</Citation><ArticleIdList><ArticleId IdType="pubmed">26765768</ArticleId></ArticleIdList></Reference><Reference><Citation>Atassi N, Xu M, Triantafyllou C, Keil B, Lawson R, Cernasov P, Ratti E, Long CJ, Paganoni S, Murphy A, Salibi N, Seethamraju R, Rosen B, Ratai EM (2017) Ultra high-field (7tesla) magnetic resonance spectroscopy in amyotrophic lateral sclerosis. PLoS One 12(5):e0177680</Citation><ArticleIdList><ArticleId IdType="pubmed">28498852</ArticleId><ArticleId IdType="pmc">5428977</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheong I, Marjanska M, Deelchand DK, Eberly LE, Walk D, Oz G (2017) Ultra-high field proton MR spectroscopy in early-stage amyotrophic lateral sclerosis. Neurochem Res 42(6):1833&#x2013;1844</Citation><ArticleIdList><ArticleId IdType="pubmed">28367604</ArticleId><ArticleId IdType="pmc">5488866</ArticleId></ArticleIdList></Reference><Reference><Citation>Seelaar H, Rohrer JD, Pijnenburg YA, Fox NC, van Swieten JC (2011) Clinical, genetic and pathological heterogeneity of frontotemporal dementia: a review. J Neurol Neurosurg Psychiatry 82(5):476&#x2013;486</Citation><ArticleIdList><ArticleId IdType="pubmed">20971753</ArticleId></ArticleIdList></Reference><Reference><Citation>Sako W, Abe T, Izumi Y, Harada M, Kaji R (2016) Fractional anisotropy in the supplementary motor area correlates with disease duration and severity of amyotrophic lateral sclerosis. Neurol Sci 37(4):573&#x2013;577</Citation><ArticleIdList><ArticleId IdType="pubmed">26809951</ArticleId></ArticleIdList></Reference><Reference><Citation>Tzourio-Mazoyer N, Landeau B, Papathanassiou D, Crivello F, Etard O, Delcroix N, Mazoyer B, Joliot M (2002) Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage 15(1):273&#x2013;289</Citation><ArticleIdList><ArticleId IdType="pubmed">11771995</ArticleId><ArticleId IdType="pmc">11771995</ArticleId></ArticleIdList></Reference><Reference><Citation>Sako W, Fujita K, Vo A, Rucker JC, Rizzo JR, Niethammer M, Carbon M, Bressman SB, Ulu&#x11f; AM, Eidelberg D (2015) The visual perception of natural motion: abnormal task-related neural activity in DYT1 dystonia. Brain 138(Pt 12):3598&#x2013;3609</Citation><ArticleIdList><ArticleId IdType="pubmed">26419798</ArticleId><ArticleId IdType="pmc">4840548</ArticleId></ArticleIdList></Reference><Reference><Citation>Sako W, Abe T, Izumi Y, Yamazaki H, Matsui N, Harada M, Kaji R (2017) Spontaneous brain activity in the sensorimotor cortex in amyotrophic lateral sclerosis can be negatively regulated by corticospinal fiber integrity. Neurol Sci 38(5):755&#x2013;760</Citation><ArticleIdList><ArticleId IdType="pubmed">28150100</ArticleId></ArticleIdList></Reference><Reference><Citation>Jenkinson M, Bannister P, Brady M, Smith S (2002) Improved optimization for the robust and accurate linear registration and motion correction of brain images. Neuroimage 17(2):825&#x2013;841</Citation><ArticleIdList><ArticleId IdType="pubmed">12377157</ArticleId></ArticleIdList></Reference><Reference><Citation>Biswal B, Yetkin FZ, Haughton VM, Hyde JS (1995) Functional connectivity in the motor cortex of resting human brain using echo-planar MRI. Magn Reson Med 34(4):537&#x2013;541</Citation><ArticleIdList><ArticleId IdType="pubmed">8524021</ArticleId></ArticleIdList></Reference><Reference><Citation>Lowe MJ, Mock BJ, Sorenson JA (1998) Functional connectivity in single and multislice echoplanar imaging using resting-state fluctuations. Neuroimage 7(2):119&#x2013;132</Citation><ArticleIdList><ArticleId IdType="pubmed">9558644</ArticleId></ArticleIdList></Reference><Reference><Citation>Zang Y, Jiang T, Lu Y, He Y, Tian L (2004) Regional homogeneity approach to fMRI data analysis. Neuroimage 22(1):394&#x2013;400</Citation><ArticleIdList><ArticleId IdType="pubmed">15110032</ArticleId></ArticleIdList></Reference><Reference><Citation>Block W, Karitzky J, Traber F, Pohl C, Keller E, Mundegar RR et al (1998) Proton magnetic resonance spectroscopy of the primary motor cortex in patients with motor neuron disease: subgroup analysis and follow-up measurements. Arch Neurol 55(7):931&#x2013;936</Citation><ArticleIdList><ArticleId IdType="pubmed">9678310</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheong I, Deelchand DK, Eberly LE, Marja&#x144;ska M, Manousakis G, Guliani G, Walk D, &#xd6;z G (2019) Neurochemical correlates of functional decline in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 90(3):294&#x2013;301</Citation><ArticleIdList><ArticleId IdType="pubmed">30467209</ArticleId></ArticleIdList></Reference><Reference><Citation>Fiszman ML, Ricart KC, Latini A, Rodriguez G, Sica RE (2010) In vitro neurotoxic properties and excitatory aminoacids concentration in the cerebrospinal fluid of amyotrophic lateral sclerosis patients. Relationship with the degree of certainty of disease diagnoses. Acta Neurol Scand 121(2):120&#x2013;126</Citation><ArticleIdList><ArticleId IdType="pubmed">19804473</ArticleId></ArticleIdList></Reference><Reference><Citation>Milanese M, Giribaldi F, Melone M, Bonifacino T, Musante I, Carminati E, Rossi PIA, Vergani L, Voci A, Conti F, Puliti A, Bonanno G (2014) Knocking down metabotropic glutamate receptor 1 improves survival and disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis. Neurobiol Dis 64:48&#x2013;59</Citation><ArticleIdList><ArticleId IdType="pubmed">24361555</ArticleId></ArticleIdList></Reference><Reference><Citation>Rothstein JD, Martin LJ, Kuncl RW (1992) Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis. N Engl J Med 326(22):1464&#x2013;1468</Citation><ArticleIdList><ArticleId IdType="pubmed">1349424</ArticleId></ArticleIdList></Reference><Reference><Citation>Sage CA, Peeters RR, Gorner A, Robberecht W, Sunaert S (2007) Quantitative diffusion tensor imaging in amyotrophic lateral sclerosis. Neuroimage 34(2):486&#x2013;499</Citation><ArticleIdList><ArticleId IdType="pubmed">17097892</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohammadi B, Kollewe K, Samii A, Krampfl K, Dengler R, Munte TF (2009) Changes of resting state brain networks in amyotrophic lateral sclerosis. Exp Neurol 217(1):147&#x2013;153</Citation><ArticleIdList><ArticleId IdType="pubmed">19416664</ArticleId></ArticleIdList></Reference><Reference><Citation>Keil C, Prell T, Peschel T, Hartung V, Dengler R, Grosskreutz J (2012) Longitudinal diffusion tensor imaging in amyotrophic lateral sclerosis. BMC Neurosci 13:141</Citation><ArticleIdList><ArticleId IdType="pubmed">23134591</ArticleId><ArticleId IdType="pmc">3531302</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J, Yin X, Zhao L, Evans AC, Song L, Xie B, Li H, Luo C, Wang J (2014) Regional alterations in cortical thickness and white matter integrity in amyotrophic lateral sclerosis. J Neurol 261(2):412&#x2013;421</Citation><ArticleIdList><ArticleId IdType="pubmed">24452838</ArticleId></ArticleIdList></Reference><Reference><Citation>Corcia P, Tauber C, Vercoullie J, Arlicot N, Prunier C, Praline J, Nicolas G, Venel Y, Hommet C, Baulieu JL, Cottier JP, Roussel C, Kassiou M, Guilloteau D, Ribeiro MJ (2012) Molecular imaging of microglial activation in amyotrophic lateral sclerosis. PLoS One 7(12):e52941</Citation><ArticleIdList><ArticleId IdType="pubmed">23300829</ArticleId><ArticleId IdType="pmc">3534121</ArticleId></ArticleIdList></Reference><Reference><Citation>Danbolt NC (2001) Glutamate uptake. Prog Neurobiol 65(1):1&#x2013;105</Citation><ArticleIdList><ArticleId IdType="pubmed">11369436</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>